ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.67796
-0.06%
Brent Oil
82.14
0.20%
Bitcoin
68,708.55
0.29%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Ocugen Inc (OCGN)

  7. Ocugen Inc (OCGN) Noticias

OCGN Ocugen Inc

1.73
-0.05 (-2.81%)
24 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Ocugen Inc OCGN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.05 -2.81% 1.73 18:59:46
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.77 1.71 1.82 1.75 1.78
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
20/5/202406:00GLOBEOcugen Announces CSO to Present on Modifier Gene Therapy..
17/5/202415:30EDGAR2Form PRE 14A - Other preliminary proxy statements
15/5/202405:30GLOBEOcugen Announces Dosing Completion of Subjects with..
14/5/202414:54EDGAR2Form 8-K - Current report
14/5/202407:00GLOBEOcugen Provides Business Update with First Quarter 2024..
14/5/202406:18IHMARKETNEWSUS Futures Remain Steady Amid Wall Street Caution Ahead of..
14/5/202405:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202415:15EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
10/5/202415:14EDGAR2Form 8-K - Current report
10/5/202415:05GLOBEOcugen Announces Distribution of Series C Preferred Stock to..
10/5/202406:45GLOBEOcugen to Present at May 2024 Investor Conferences
03/5/202406:30GLOBEOcugen to Host Conference Call on Tuesday, May 14 at 8:30..
02/5/202406:15GLOBEOcugen Announces CSO to Present on Modifier Gene Therapy at..
29/4/202405:45GLOBEOcugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data..
26/4/202408:05GLOBEUPDATE -- Ocugen to Present on Modifier Gene Therapy..
26/4/202405:30GLOBEOcugen to Present on Modifier Gene Therapy Platform at..
19/4/202406:13GLOBEOcugen Announces Dosing Completion of Subjects with..
12/4/202406:30GLOBEOcugen to Participate in Fireside Chat at the Emerging..
10/4/202406:02GLOBEOcugen, Inc. Announces Positive Scientific Advice from the..
08/4/202405:30GLOBEOcugen, Inc. Announces U.S. FDA Clearance of IND Amendment..
05/4/202406:02GLOBEOcugen Announces Positive Data and Safety Monitoring Board..
02/4/202407:00GLOBEOcugen Provides Business Update with Certain Financials for..
01/4/202417:08GLOBEOcugen Announces Positive Data and Safety Monitoring Board..
01/4/202416:43GLOBEOcugen to Host Conference Call on Tuesday, April 2 at 8:30..
18/3/202405:30GLOBEOcugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical..
13/3/202407:00GLOBEOcugen, Inc. Announces Dosing Completion of Subjects with..
06/3/202406:30GLOBEOcugen to Present at Investing in Cures Summit
28/2/202407:00GLOBEOcugen Clinical Showcase Webcast Now Available
26/2/202407:30GLOBEOcugen Chairman and CEO to present at Abu Dhabi Family..
22/2/202415:05GLOBEOcugen, Inc. Announces Dosing Completion of Subjects with..
21/2/202415:05GLOBEOcugen to Present at 2024 BIO CEO & Investor Conference
21/2/202410:22EDGAR2Form 8-K - Current report
14/2/202406:30GLOBEOcugen to Host Clinical Showcase in New York City..
31/1/202407:00GLOBEOcugen to Present at Pharma Market Research Conference
16/1/202406:30GLOBEOcugen, Inc. Announces Bob Smith Joins Business Advisory..
08/1/202405:05EDGAR2Form 8-K - Current report
05/1/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202314:09EDGAR2Form 8-K - Current report
21/12/202305:30GLOBEOcugen Gains FDA Alignment on Key Aspects of OCU400—Modifier..
19/12/202306:30GLOBEOcugen Announces OCU400 Receives Regenerative Medicine..
13/12/202306:30GLOBEOcugen, Inc. Announces First Patient Dosed in Phase 1/2..
29/11/202306:30GLOBEOcugen CEO to Present at NobleCon19 – Noble Capital Markets’..
10/11/202306:30GLOBEOcugen, Inc. Announces First Patient Dosed in Phase 1/2..
09/11/202307:02EDGAR2Form 8-K - Current report
09/11/202306:02EDGAR2Form 8-K - Current report
09/11/202305:30GLOBEOcugen Provides Business Update with Third Quarter 2023..
09/11/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

NASDAQ
OCGN
Ocugen
LSE
0MW1
Stockmann Oyj Abp
BIT
F25385
Vontobel Financial Produ...
LSE
0P2X
Zue
TSXV
DSY
Destiny Media Technologies
ASX
TMGO
Trigg Minerals
EU
ALMII
M2I
LSE
HANA
Hansa Investment
ASX
TPC
TPC Consolidated
LSE
0MEF
Rapala Vmc
NYSE
LEA
Lear
BIT
P1HXB6
BNP Paribas Issuance
BOV
HOOT4Q
HOTEIS OTHON PN
BIT
P1RB34
BNP Paribas Issuance
BIT
1GLW
Corning
BIT
I06298
Banca Imi
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados